[1]
T. Vojinović, J. Djuris, Z. Potpara, and S. Ibric, “Oral lipid formulation type IV as an approach in the formulation of solid dosage forms with poorly soluble substances: Chremophor®RH 40 as a surfactant phase”, Progr Nutr, vol. 23, no. 3, p. e2021279, Oct. 2021.